Talk:Injection site reaction

Article categorization

This article was categorized based on scheme outlined at WP:DERM:CAT. kilbad (talk) 00:58, 3 February 2009 (UTC)

Broadening scope of article

The article as it stands only refers to IV infusions and IM injections. Moreover, it says they result in cutaneous necrosis. Unless there is another article with a similar name I should be linking to instead, this article should also include less severe ISRs, those that typically resolve with no intervention in a short duration and have no lasting effects. My reason for this suggestion is that most literature around self-administered subcutaneous injections, such as the antibodies Tremfya and Taltz, but also GLP1 drugs like Mounjaro, etc all use the term "injection site reaction" in the manner I described above. In general the term in these contexts includes: bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site. Some of these are obviously more or less common than others, and so perhaps the list could be pared down. I'd like to be able to wikilink from the drugs' articles listed above, where they simply say "injection site reactions", to a page detailing what those ISRs are, especially considering for many of these drugs, ISRs are the most common adverse effect. I'm going to try to change the article in this way. Kimen8 (talk) 20:29, 31 October 2023 (UTC)